Redwood Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-491,123
Closed -$9.21M 126
2023
Q1
$9.21M Sell
491,123
-215,570
-31% -$3.54M 1.18% 39
2022
Q4
$9.73M Sell
706,693
-14,015
-2% -$215K 1.3% 33
2022
Q3
$13.8M Sell
720,708
-166,240
-19% -$3.03M 1.85% 14
2022
Q2
$13.5M Buy
886,948
+131,216
+17% +$1.94M 1.5% 28
2022
Q1
$15.4M Sell
755,732
-16,541
-2% -$337K 1.46% 29
2021
Q4
$22.5M Buy
+772,273
New +$22.1M 1.78% 19

Other funds holding CDMO

Redwood Investments's CDMO Position: Q2 2023 in Review

Redwood Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 491,123 shares — an estimated $9.21M sold.

Redwood Investments first reported a position in CDMO in Q4 2021 and held it in 6 quarters. The position peaked at $22.5M in Q4 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

  • Redwood Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Redwood Investments sold 491,123 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $9.21M.
  • Redwood Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Redwood Investments's Avid Bioservices, Inc. Common Stock position peaked at $22.5M in Q4 2021.
  • 169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on Redwood Investments's 13F filing for Q2 2023, filed 24 Jul 2023.